Aktie A2AP5P NUO THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Nuo Therapeutics, Inc.

Aktien

A2AP5P

US67059V2097

AURX

Markt geschlossen - OTC Markets
Andere Börsenplätze
 15:51:14 15.05.2024 		% 5 Tage % 1. Jan.
0,75 USD 0,00 % Intraday Chart für Nuo Therapeutics, Inc. -6,25 % +36,36 %
19.04. Nuo Therapeutics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
19.03. Die von Exor unterstützte NUO investiert in die italienische Teenager-Bekleidungskette Subdued RE

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Exor-backed NUO invests in Italian teenage clothing chain Subdued
Nuo Therapeutics, Inc. announced that it has received $0.9625 million in funding
Nuo Therapeutics, Inc. announced that it expects to receive $0.9625 million in funding
Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nuo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Insider Buy: Nuo Therapeutics
Nuo Therapeutics, Inc. announced that it has received $1.035 million in funding
Nuo Therapeutics, Inc. announced that it expects to receive $1.035 million in funding
Nuo Therapeutics Selects to Exhibit Aurix® System At Vizient Innovative Technology Exchange
Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage
Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Nuo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AP5P Aktie
  4. Nachrichten Nuo Therapeutics, Inc.
  5. Andere Sprachen